Search Results

His undergraduate thesis work on studying the biochemical mechanisms of flavonoids in cancer using nuclear been recognized with the MRC LMB's Max Perutz Prize for outstanding Ph.D. work and has been elected a Research

Endocrinology, and Taste GPCRs in Neuroscience GPCRs in Oncology and Immunology Methods & Updates in GPCR Research Agonist Danuglipron Read More April 22, 2025 Collaboration between Nostrum Biodiscovery and Celtarys Research 2025 SIGMAR1 screened by a GPCR-related classifier regulates endoplasmic reticulum stress in bladder cancer Read More April 7, 2025 G-protein coupled receptors in metabolic reprogramming and cancer Read More more April 18, 2025 Discovery of Feeding Regulatory Peptides and The Importance of Peptide Discovery Research

After switching to biotech, Murat has built cell imaging software and lab robots to accelerate cancer research and automated Thermo Fisher Scientific’s gene synthesis workflows.

A large component of his work is centered around dysregulated signaling in cancer and the development of novel mechanism-based cancer therapies. Silvio Gutkind on the web Gutkind Lab – UC San Diego Moores Cancer Center Gutkind Lab publications More J Silvio Gutkind on LinkedIn Gutkind Lab on Twitter UCSD Moores Cancer Center Dr.

Kenakin begins by discussing how antagonists produce different curve patterns, aiding researchers in receptor systems, using examples like the impact of inverse agonists on overexpressed receptors in cancer research.

Explore the scientific conference program at DrGPCR for cutting-edge insights in GPCR research. Get to know more: Celtarys Research | Dr. GPCR Ecosystem | Dr. GPCRpodcast #OpioidPharmacology #DrugDiscovery May 12, 2025 Disrupting VIPR2 dimerisation halts breast cancer spread—could TM3-4 peptides be the next breakthrough in targeted cancer therapy? dimerisation-of-the-vip-receptor-vipr2-is-essential-to-its-binding-vip-and-g%CE%B1i-proteins%2C-and-to-its-functions-in-breast-cancer-cells

In this episode, Silvio discusses G protein signaling in the context of cancer, immunotherapies, and J Silvio Gutkind on LinkedIn Gutkind Lab – UC San Diego Moores Cancer Center Gutkind Lab publications Gutkind Lab on Pubmed Gutkind Lab on Twitter UCSD Moores Cancer Center Dr.

Like many, his path to GPCR research wasn’t linear—it evolved through academic exploration and mentorship discovery… I was in love with the topic.” – Alessandro Nicoli Working on docking and NMR studies for cancer-related From Researcher to Mentor: Growing Together Outside his research, Nicoli mentors students, manages interns Advice, Tools, and the Future of GPCR Research Nicoli offered advice to wet-lab scientists curious about Keyword Cloud GPCR research community , Dr.

GPCR Podcast << Back to podcast list Exploring Career Paths in GPCR Research with Dr. After completing his Ph.D., he pursued research in genetics of metabolic regulation at the Institute Since 2021, Jacek has been working at Novo Nordisk at its research sites in the UK (Oxford) and the US of method development, integrity, and honesty in scientific research. their research interests and achievements, particularly in the field of GPCR.

As part of the degree, she undertook a 1-year research-based placement at the Charles Perkins Centre From here, she returned to the UK. Annabelle Milner on the web Linkedin Researchgate Pubmed Dr.

My postdoctoral work, conducted at the University of Bristol, UK, in Christopher Lowry's lab, examined Research in my lab is currently focused on understanding the signal transduction pathways activated by Gasser on the web Gasser Lab Marquette University Google Scholar ResearchGate LinkedIn Twitter Dr.

world-class and diverse GPCR scientists working in the arenas of structure and signaling, neuroscience, cancer We are thrilled by the overwhelming interest in this event by the GPCR research community. postdoctoral fellows and principal investigators can have stimulating discussions and debates on GPCR research

Trained as a biochemist, he completed a PhD in protein engineering (Cambridge, UK) with Sir Gregory Winter Since then Oliver has worked at the University of Geneva, where his research on peptide engineering and high-profile publications and new intellectual property, and at the Mintaka Foundation for Medical Research

The company’s mission is to discover and develop highly effective cancer therapeutics by targeting heteromers Cardarelli heads the team of talented researchers that will be expanding at the US site. Dr.

Richard Henderson at the Laboratory of Molecular Biology in Cambridge, UK. Marshall is the VP Head of Neuroscience Discovery and Head of Discovery UK, Global Head of Neuroscience discovery research leading teams in West Point, Boston, and London at MSD. Fiona Marshall on the web LinkedIn Twitter Google Scholar MSD UK Dr.

Date & Time Friday, November 3rd / 8:30 AM Abstract Coming Soon About Mario Tiberi "I did my graduate research My addiction for dopamine led me to the Ottawa Hospital Research Institute (then the Moses and Rose Loeb Research Institute) to develop my independent research program. We are also currently developing the translational component of our research to capitalize on the druggability We hope our research will aid in the development of new therapeutic interventions for the alleviation

Robert Laprairie is an Associate Professor and the Saskatchewan Research Chair in Drug Discovery and The focus of his research is the molecular pharmacology of cannabinoids and cannabinoid receptors. Investigator of the Year Awards from the British Pharmacological Society and International Cannabinoid Research Robert Laprairie on the web University of Saskatchewan Twitter Instagram ResearchGate Google Scholar

He has held four Canada Research Chairs since 2001 and was previously a Heart and Stroke Foundation of His research career has focused on the investigation of the regulation of G protein-coupled receptors He currently holds multiple research grants from the Canadian Institutes of Health Research (CIHR) for his research investigating the role of metabotropic glutamate receptor signaling in Huntington’s and Stephen Ferguson on the web Carlton University Canada Research Chairs Twitter ResearchGate LinkedIn Dr

His research focuses on novel paradigms of drug action at GPCRs, particularly allosteric modulation and Since 2014, Clarivate Analytics have annually named him a Highly Cited Researcher in ‘Pharmacology & Targets Arthur shared his decision to undertake a postdoctoral position with Nigel Bird's lab in the UK GPCR researchers in Australia and the initiation of a successful series of conferences. and its capacity to translate research into therapeutic commercialization.

His research focuses on novel paradigms of drug action at GPCRs, particularly allosteric modulation and Since 2014, Clarivate Analytics have annually named him a Highly Cited Researcher in ‘Pharmacology & Targets Arthur shared his decision to undertake a postdoctoral position with Nigel Bird's lab in the UK GPCR researchers in Australia and the initiation of a successful series of conferences. and its capacity to translate research into therapeutic commercialization.

He has held four Canada Research Chairs since 2001 and was previously a Heart and Stroke Foundation of His research career has focused on the investigation of the regulation of G protein-coupled receptors He currently holds multiple research grants from the Canadian Institutes of Health Research (CIHR) for his research investigating the role of metabotropic glutamate receptor signaling in Huntington’s and Stephen Ferguson on the web Carlton University Canada Research Chairs Twitter ResearchGate LinkedIn Dr

Debbie obtained a Ph.D. in Molecular Pharmacology from Imperial College London in the UK. Hay on the web LinkedIn Wikipedia University of Otago University of Auckland Google Scholar Pubmed Research

a molecular pharmacologist at the University of Nottingham, to discuss his scientific journey, GPCR research Folding to GPCRs – How Dmitry transitioned from biophysics and protein folding to cannabinoid receptor research Interdisciplinary Research & Future Directions – Exploring combinatorial drug actions, receptor interactions MRC Centre for Protein Engineering and later at the MRC Laboratory of Molecular Biology in Cambridge, UK

. 🧬 Tumor models illustrate the challenges of drug penetration in cancer treatment. 💡 Lower affinity This can influence the interpretation of experimental data. 🎯 Tumor Targeting: In cancer therapy, ensuring

During four years of postdoctoral research at ETH Zurich and the Paul Scherrer Institute in Switzerland Cell Signaling and Cancer Metastasis Discussion Aurelien Rizk and Yamina Berchiche had a detailed conversation Yamina shared her research experience, emphasizing the fascination of understanding how cells respond to gradients and signals, particularly in relation to cancer metastasis.

During his last year of studies, Timo performed research in the biopharmaceutical company Argen X and Raimond Heukers , developed a nanobody platform within the research group and used this platform to develop During his Ph.D., he used these nanobodies as research tools, to investigate different GPCR conformations Starting from September 2019, Timo started working as a postdoctoral researcher at the Vrije Universiteit future, Timo hopes to combine his previous GPCR experience with his current focus to set up his own research

Saraf " My research focuses on evaluating and targeting serotonin 1A receptors for therapeutic outcomes Saraf on the web FRAXA Research Foundation Google Scholar ResearchGate LinkedIn Dr.

Graeme Milligan Professor Graeme Milligan is Gardiner Professor of Biochemistry, Dean of Research, and His main research group centers on the function, structure, and regulation of G protein-coupled receptors Milligan has published more than 550 peer-reviewed articles and his research has been cited more than Graeme Milligan on the web University of Glasgow ResearchGate PubMed Orcid Google Scholar LinkedIn Dr